SOLICITATION NOTICE
A -- U.S. ARMY RESEARCH OFFICE BROAD AGENCY ANNOUNCEMENT FOR DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) ADVANCED TECHNOLOGY OFFICE (ATO) ODORTYPE DETECTION PROGRAM
- Notice Date
- 12/13/2002
- Notice Type
- Solicitation Notice
- Contracting Office
- US Army Robert Morris Acquisition Center, ATTN: AMSSB-ACR, Research Triangle Park Contracting Division, P.O. Box 12211, Research Triangle Park, NC 27709-2211
- ZIP Code
- 27709-2211
- Solicitation Number
- DAAD19-03-R-0004
- Archive Date
- 3/30/2003
- Point of Contact
- Lida Barton, 919-549-4266
- E-Mail Address
-
Email your questions to US Army Robert Morris Acquisition Center
(barton@aro.arl.army.mil)
- Small Business Set-Aside
- N/A
- Description
- NA The U.S. Army Research Office (ARO) announces the availability of Broad Agency Announcement (BAA) No. DAAD19-03-R-0004 dated December 2002 for the Defense Advanced Research Projects Agency (DARPA) Advanced Technology Office (ATO) Odortype Detection Program . The DARPA ATO is soliciting innovative proposals to (1) determine whether genetically-determined odortypes can be used to identify specific individuals, and if so (2) to develop the science and enabling technology for detecting and identifying specific individuals by such odortypes. The Odortype Detection program will leverage research that has demonstrated that the same set of genes that code for internal immune system self/non-self recognition in mice ? the Major Histocompatibility Complex (MHC) ? als o code for individual odortype. Although experimental data for humans is far less quantitative, behavioral studies have yielded compelling results to suggest that such MHC-determined odor individuality can also be expected in humans. Recent experimental results with mice suggest that MHC-determined urinary odor is expressed as a mixture of volatile carboxylic acids occurring in relative concentrations that are characteristic of the odortype. This suggests the possibility of an exploitable chemosignal cor responding to an individual?s genetically determined odortype. This effort will be divided into two phases. The goal of phase 1 will be to determine whether an exploitable, robust signature corresponding to individual human odortype exists. The goal of phase 2 will be to build a detector that can reliably detect the signature identified in phase one with high sensitivity and specificity. Proposals that focus only on phase 2 will not be considered for this solicitation. Multiple awards are anticipated. Total program funding for this research and development effort shall not exceed $3,200,000 in FY 2003. The BAA provides further information on the above areas of interest, proposal format, submission instructions, evaluation process, and other informati on. Proposals must be received at DARPA not later than 1600 local time on January 29, 2003. This BAA may be electronically downloaded from ARO?s website at http://www.aro.army.mil/research/index.htm.
- Record
- SN00223371-W 20021215/021213213800 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |